Physical Pharmacy and Formulation
A section of Pharmaceutics (ISSN 1999-4923).
Section Information
This section is intended to rapidly publish all aspects of current issues in physicochemical characterization of drug substances including proteins, and their formulation design and products development. An example of specific topics includes but not limited to:
Physical Pharmacy
- Solubility
- Solubilization
- Dissolution
- Polymorphism
- Permeability
- Stability and stabilization
- New materials for controlling drug characteristics
- Analytical techniques
Formulation
- Novel excipients
- Formulation science
- Drug delivery systems
- Controlled release
- Drug targeting
- Bioavailability
- Quality-by-design
- Regulatory science
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Pharmaceutical Polymorphs and Cocrystals and Their In Vitro and In Vivo Evaluation (Deadline: 20 July 2025)
- Pharmaceutical Formulation of Novel Bioactive Molecules from Marine Sources (Deadline: 20 July 2025)
- Formulation of Recombinant Therapeutic Proteins (Deadline: 20 July 2025)
- Pharmaceutical Excipients: Impact on Efficiency, Stability, and Solubility in Formulation (Deadline: 31 July 2025)
- Mucosal Drug Delivery: Exploring Novel Approaches and Formulations (Deadline: 31 July 2025)
- Antimicrobial Resistance and Antimicrobial Activity of Bioactive Compounds in Drug Formulations (Deadline: 31 July 2025)
- Advances in Inhalation Formulations: Innovations and Analytical Approaches for Pulmonary and Nasal Drug Delivery (Deadline: 31 July 2025)
- Recent Advances in Injectable Formulations (Deadline: 31 July 2025)
- Solid Dispersions for Drug Delivery: Development, Preparation and In Vitro/In Vivo Characterization (Deadline: 31 July 2025)
- Advanced Pediatric Drug Formulation Strategies (Deadline: 10 August 2025)
- Advances in Inhaled Formulations for Pulmonary Drug Delivery (Deadline: 20 August 2025)
- Development and Optimization of Buccal Films Formulations (Deadline: 31 August 2025)
- Pharmaceutical Solid Dosage Forms: Manufacturing, Design, Development, and Biomedical Applications (Deadline: 31 August 2025)
- Advancements in Tablet Formulation and Technological Innovations in Pharmaceutical Manufacturing (Deadline: 31 August 2025)
- Recent Advances in Cocrystal and Nano-Cocrystal Technologies for Pharmaceutical and Nutraceutical Applications (Deadline: 31 August 2025)
- Advanced Research on Amorphous Drugs (Deadline: 31 August 2025)
- Development and Evaluation of Inhalable Dry Powder Formulations, 2nd Edition (Deadline: 31 August 2025)
- Advances in Pharmaceutical Cocrystal Design and Technological Applications (Deadline: 10 September 2025)
- Novel Biomaterials for Bone Regeneration (Deadline: 20 September 2025)
- Dosage Form Design and Delivery Therapy for Skin Disorders (Deadline: 30 September 2025)
- New Frontiers in Therapies, Diagnostics and Biomedical Engineering of Clay-Based Materials (Deadline: 30 September 2025)
- Development of Skin Barrier Repair Therapy Formulations for Skin Care Purposes (Deadline: 30 September 2025)
- Drug Stability in Oral Administration (Deadline: 30 September 2025)
- Preparation and Development of Amorphous Solid Dispersions (Deadline: 30 September 2025)
- Excipients in the Design and Development of Pharmaceutical Formulations (Deadline: 30 September 2025)
- Emerging Drugs and Formulations for Pain Treatment (Deadline: 10 October 2025)
- Pharmacy Compounding of Personalized Preparation for Specific Patients: Challenges and Advantages, 2nd Edition (Deadline: 20 October 2025)
- Ionic Liquids in Pharmaceutical and Biomedical Applications, 2nd Edition (Deadline: 30 October 2025)
- Advances in Analysis and Modeling of Solid Drug Product (Deadline: 31 October 2025)
- Aspects and Implementation of Pharmaceutical Quality by Design, 2nd Edition (Deadline: 31 October 2025)
- Nanotechnology in Formulation of Tumor-Targeted Drug Delivery Systems (Deadline: 31 October 2025)
- Technology and Preparation of Solid Dispersion for the Enhancement of Oral Bioavailability (Deadline: 31 October 2025)
- Extemporaneous Formulations: Filling the Gap in the Pharmaceutical Industry with Personalized Medicines (Deadline: 31 October 2025)
- Drug Formulations Based on Chitosan and Its Derivatives for Therapeutic Applications (Deadline: 20 November 2025)
- Long Acting Drug Delivery Formulations (Deadline: 20 November 2025)
- A New Generation of Metal Anticancer Drugs (Deadline: 30 November 2025)
- Formulation, Characterization, and Performance Testing of Topical Semisolid Products (Deadline: 30 November 2025)
- Model-Based Formulation Strategies for Controlled Release of Active Ingredients (Deadline: 30 November 2025)
- Phytocompounds-Based Formulations for Anti-Inflammatory Disorders (Deadline: 20 December 2025)
- Advances in Amorphous Solid Dispersions (Deadline: 20 December 2025)
- Drug Polymorphism and Dosage Form Design, 2nd Edition (Deadline: 26 December 2025)
- Application of Marine-Derived Polymers in Drug Dosage Forms (Deadline: 31 December 2025)
- Paediatric and Neonatal Specific Dosage Forms and Administration (Deadline: 31 December 2025)
- Bioactive Hydrogels as Multifunctional Dressing Materials (Deadline: 31 December 2025)
- Recent Advances in 3D Printing of Pharmaceutical Dosage Forms (Deadline: 31 December 2025)
- Advances and Challenges in Nasal Formulation Developments, 3rd Edition (Deadline: 31 December 2025)
- Exploring the Versatility of Cyclodextrins in Pharmaceutical Formulations (Deadline: 31 December 2025)
- Natural Product Pharmaceuticals, 2nd Edition (Deadline: 31 December 2025)
- Innovative Approaches in Skin Formulation Development and Characterization: Scientific Foundations for Regulatory Transformation (Deadline: 31 December 2025)
- New Trends in the Controlled Release Systems of Medicinal Substances Used in the Treatment of Diseases of the Central Nervous System (Deadline: 31 December 2025)
- Inhaled Medicines: Past, Present and Future (Deadline: 31 December 2025)
- Emerging Strategies to Enhance Solubility of Poorly Soluble Drugs: From Nanosystems to Molecular Innovations (Deadline: 31 January 2026)
- Stability of Medicines and Novel Approaches for Predicting Drug Stability (Deadline: 20 February 2026)
- Probiotics in Pharmaceutics: Exploring the Therapeutic Potential and Formulation Strategies (Deadline: 28 February 2026)
- Customized Pharmaceutics: Innovations for Diverse Populations (Deadline: 28 February 2026)
- Advances in Natural Anticancer Formulation (Deadline: 28 February 2026)
- A Commemorative Issue in Honor of Professor Gregory Gregoriadis: Liposomes for the Delivery of Drugs and Vaccines (Deadline: 28 February 2026)
- Improving the Bioavailability and Solubility of Pharmaceutical Formulations (Deadline: 10 March 2026)
- Formulation Design of Lipid Nanoparticles for Pharmaceutical Applications (Deadline: 27 March 2026)
- Design and Evaluation of Pharmaceutical Co-Crystallization: Integration of Structural Analysis and Pharmacodynamic Assessment (Deadline: 31 March 2026)
- Hypromellose in Modern Pharmaceutics: From Advanced Drug Delivery to Process Optimization and Quality Control (Deadline: 20 May 2026)
Topical Collection
Following topical collection within this section is currently open for submissions:
